The role of microRNAs in myeloid cells during graft-versus-host disease

4Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

The successful treatment of various hematologic diseases with allogeneic hematopoietic cell transplantation is often limited by the occurrence of graft-versus-host disease (GvHD). Several microRNAs (miRs) have recently been shown to impact the biology of GvHD by regulating pro- as well as anti-inflammatory target genes. There is increasing evidence that a single miR can have different effects by preferentially targeting certain genes depending on the cell type that the miR is analyzed in. This review will focus on the role of miRs in myeloid cells during the development of acute and chronic GvHD and autoimmune diseases. Because miRs act on the expression of multiple target genes and may thereby influence the immune system at different functional levels, they are potentially attractive targets for the modification of allogeneic immune responses using miR mimics and inhibitors.

Cite

CITATION STYLE

APA

Chen, S., & Zeiser, R. (2018, January 23). The role of microRNAs in myeloid cells during graft-versus-host disease. Frontiers in Immunology. Frontiers Media S.A. https://doi.org/10.3389/fimmu.2018.00004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free